The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer

Clinical Lung Cancer

Volumn 6, Issue 6, 2005, Pages 331-332

  Belani, Chandra P ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; NAVELBINE; PACLITAXEL; PLATINUM DERIVATIVE;

CANCER ADJUVANT THERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; EDITORIAL; FEBRILE NEUTROPENIA; HUMAN; LUNG NON SMALL CELL CANCER; NAUSEA; NEUTROPENIA; PERIPHERAL NEUROPATHY; POSTOPERATIVE PERIOD; PROGNOSIS; RISK BENEFIT ANALYSIS; UNITED STATES; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CISPLATIN; HUMANS; LUNG NEOPLASMS; NEOADJUVANT THERAPY; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE; VINBLASTINE;

EID: 26444572402     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (6)

1. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350:351-360.
2. Winton TL, Livingston R, Johnson D, et al. A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR. 10. Late-breaking abstract from the ASCO 2004 Annual Meeting. J Clin Oncol 2004; 22(suppl):7018.
3. Strauss GM, Herndon J, Maddaus MA, et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage 1B non-small cell lung cancer (NSCLC): report of Cancer and Leukemia Group B (CALGB) Protocol 9633. Late-breaking abstract from the ASCO 2004 Annual Meeting. J Clin Oncol 2004; 22(suppl):7019.
4. Douillard J, Rosell R, Delena A, et al. ANITA: phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association. Proc Soc Am Clin Oncol 2005; 23:624 (Abstract #7013).
5. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised dinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995; 311:899-909.
6. Pisters KP, Vallieres E, Bunn P, et al. S9900: a phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): preliminary results. Late-breaking abstract from the ASCO 2005 Annual Meeting. J Clin Oncol 2005; 23(suppl):7012.